SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Stock Picking - 2002

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: michael_f_murphy who started this subject3/26/2002 4:44:00 PM
From: schzammm  Read Replies (1) of 308
 
Mike,

siliconinvestor.com

-- Cytyc Corporation (Nasdaq: CYTC chart, msgs) and Digene Corporation (Nasdaq: DIGE chart, msgs) today announced that Cytyc, through its wholly-owned subsidiary Cruiser, Inc., has commenced its previously announced exchange offer for all outstanding shares of Digene common stock.

Under the terms of the exchange offer, each Digene shareholder will receive $4.00 per share in cash plus 1.1969 shares of Cytyc common stock for every share of Digene common stock validly tendered and not properly withdrawn.

The exchange offer is scheduled to expire at 12:00 midnight, New York City time, on Thursday, March 28, 2002, unless extended.

One other item, I should also mention. When I selected two Canadian stocks, I divided the $10,000 by the Canadian $ quote so I show fewer shares on my portfolio than I actually own. I did this because the quotes on SI are C$. How would you like to resolve the two issues mentioned.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext